Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

RNA-seq reveals transcriptome changes in goats following myostatin gene knockout.

Wang L, Cai B, Zhou S, Zhu H, Qu L, Wang X, Chen Y.

PLoS One. 2017 Dec 11;12(12):e0187966. doi: 10.1371/journal.pone.0187966. eCollection 2017.

2.

Alcoholic Myopathy: Pathophysiologic Mechanisms and Clinical Implications.

Simon L, Jolley SE, Molina PE.

Alcohol Res. 2017;38(2):207-217.

3.

The histone deacetylase SIRT6 blocks myostatin expression and development of muscle atrophy.

Samant SA, Kanwal A, Pillai VB, Bao R, Gupta MP.

Sci Rep. 2017 Sep 19;7(1):11877. doi: 10.1038/s41598-017-10838-5.

4.

Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment.

Verzola D, Milanesi S, Bertolotto M, Garibaldi S, Villaggio B, Brunelli C, Balbi M, Ameri P, Montecucco F, Palombo D, Ghigliotti G, Garibotto G, Lindeman JH, Barisione C.

Sci Rep. 2017 Apr 13;7:46362. doi: 10.1038/srep46362.

5.

Supraphysiological levels of GDF11 induce striated muscle atrophy.

Hammers DW, Merscham-Banda M, Hsiao JY, Engst S, Hartman JJ, Sweeney HL.

EMBO Mol Med. 2017 Apr;9(4):531-544. doi: 10.15252/emmm.201607231.

6.

The effect of eight weeks resistance and aerobic training on myostatin and follistatin expression in cardiac muscle of rats.

Rashidlamir A, Attarzadeh Hosseini SR, Hejazi K, Motevalli Anberani SM.

J Cardiovasc Thorac Res. 2016;8(4):164-169. doi: 10.15171/jcvtr.2016.33. Epub 2016 Dec 30.

7.

Sarcopenia in heart failure: mechanisms and therapeutic strategies.

Collamati A, Marzetti E, Calvani R, Tosato M, D'Angelo E, Sisto AN, Landi F.

J Geriatr Cardiol. 2016 Jul;13(7):615-24. doi: 10.11909/j.issn.1671-5411.2016.07.004. Review.

8.

Silencing Myostatin Using Cholesterol-conjugated siRNAs Induces Muscle Growth.

Khan T, Weber H, DiMuzio J, Matter A, Dogdas B, Shah T, Thankappan A, Disa J, Jadhav V, Lubbers L, Sepp-Lorenzino L, Strapps WR, Tadin-Strapps M.

Mol Ther Nucleic Acids. 2016 Aug 2;5(8):e342. doi: 10.1038/mtna.2016.55.

9.

Cardiac cachexia: hic et nunc.

Loncar G, Springer J, Anker M, Doehner W, Lainscak M.

J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):246-60. doi: 10.1002/jcsm.12118. Epub 2016 Jul 1. Review.

10.

MicroRNAs, heart failure, and aging: potential interactions with skeletal muscle.

Murach KA, McCarthy JJ.

Heart Fail Rev. 2017 Mar;22(2):209-218. doi: 10.1007/s10741-016-9572-5. Review.

11.

Cardiac-Secreted Factors as Peripheral Metabolic Regulators and Potential Disease Biomarkers.

Dewey CM, Spitler KM, Ponce JM, Hall DD, Grueter CE.

J Am Heart Assoc. 2016 May 31;5(6). pii: e003101. doi: 10.1161/JAHA.115.003101. No abstract available.

12.

Overexpression of Latent TGFβ Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFβ.

Lamar KM, Bogdanovich S, Gardner BB, Gao QQ, Miller T, Earley JU, Hadhazy M, Vo AH, Wren L, Molkentin JD, McNally EM.

PLoS Genet. 2016 May 5;12(5):e1006019. doi: 10.1371/journal.pgen.1006019. eCollection 2016 May.

13.

Is Growth Differentiation Factor 11 a Realistic Therapeutic for Aging-Dependent Muscle Defects?

Harper SC, Brack A, MacDonnell S, Franti M, Olwin BB, Bailey BA, Rudnicki MA, Houser SR.

Circ Res. 2016 Apr 1;118(7):1143-50; discussion 1150. doi: 10.1161/CIRCRESAHA.116.307962.

14.

Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation.

Walker RG, Poggioli T, Katsimpardi L, Buchanan SM, Oh J, Wattrus S, Heidecker B, Fong YW, Rubin LL, Ganz P, Thompson TB, Wagers AJ, Lee RT.

Circ Res. 2016 Apr 1;118(7):1125-41; discussion 1142. doi: 10.1161/CIRCRESAHA.116.308391. Review.

15.

Higher Plasma Myostatin Levels in Cor Pulmonale Secondary to Chronic Obstructive Pulmonary Disease.

Ju CR, Chen M, Zhang JH, Lin ZY, Chen RC.

PLoS One. 2016 Mar 21;11(3):e0150838. doi: 10.1371/journal.pone.0150838. eCollection 2016.

16.

Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?

Mueller TC, Bachmann J, Prokopchuk O, Friess H, Martignoni ME.

BMC Cancer. 2016 Feb 8;16:75. doi: 10.1186/s12885-016-2121-8. Review.

17.

The Role of Exercise in Cardiac Aging: From Physiology to Molecular Mechanisms.

Roh J, Rhee J, Chaudhari V, Rosenzweig A.

Circ Res. 2016 Jan 22;118(2):279-95. doi: 10.1161/CIRCRESAHA.115.305250. Review.

18.

Questions and Answers About Myostatin, GDF11, and the Aging Heart.

McNally EM.

Circ Res. 2016 Jan 8;118(1):6-8. doi: 10.1161/CIRCRESAHA.115.307861. No abstract available.

19.

Paracrine and endocrine modes of myostatin action.

Lee YS, Huynh TV, Lee SJ.

J Appl Physiol (1985). 2016 Mar 15;120(6):592-8. doi: 10.1152/japplphysiol.00874.2015. Epub 2016 Jan 14.

20.

Circulating Growth Differentiation Factor 11/8 Levels Decline With Age.

Poggioli T, Vujic A, Yang P, Macias-Trevino C, Uygur A, Loffredo FS, Pancoast JR, Cho M, Goldstein J, Tandias RM, Gonzalez E, Walker RG, Thompson TB, Wagers AJ, Fong YW, Lee RT.

Circ Res. 2016 Jan 8;118(1):29-37. doi: 10.1161/CIRCRESAHA.115.307521. Epub 2015 Oct 21. Erratum in: Circ Res. 2018 Jan 5;122(1):e3-e4.

Supplemental Content

Support Center